Thyroid Cancer

Cancer Epidemiology and Prevention

Volumn , Issue , 2009, Pages

  Ron, Elaine ^a   Schneider, Arthur B ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anaplastic carcinoma; Cancer epidemiology; Cancer prevention; Cancer risk; Follicular carcinoma; Papillary carcinoma; Thyroid

Indexed keywords

EID: 84920169770     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195149616.003.0050     Document Type: Chapter

References (352)

1. Abelin T, Egger M, Ruchti C. 1994. Belarus increase was probably caused by Chernobyl. Br Med J 309:1298.
2. Acharya S, Sarafoglou K, LaQuaglia M, et al. 2003. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97:2397-2403.
3. Adjadj E, Rubino C, Shamsaldim A, et al. 2003. The risk of multiple promary breast and thyroid carcinomas-role of the radiation dose. Cancer 98:1309-1317.
4. Adlercreutz CH, Goldin BR, Gorbach SL, et al. 1995. Soybean phytoestrogen intake and cancer risk. J Nutr 125:757S-770S.
5. Akslen LA, Haldorsen T, Thoresen SØ, et al. 1991. Survival and causes of death in thyroid cancer: A population-based study of 2479 cases from Norway. Cancer Res 51:1234-1241.
6. Akslen LA, Nilssen S, Kvåle G. 1992. Reproductive factors and risk of thyroid cancer. A prospective study of 63,090 women from Norway. Br J Cancer 65:772-774.
7. Al-Jurf A, Esselstyn CB, Crile G Jr. 1979. Thyroid lesions in patients with hyperparathyroidism. Int Surg 64:33-36.
8. American Joint Committee on Cancer. 1997. Thyroid Gland. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven Publishers, pp. 59-64.
9. Aozasa K. 1990. Hashimoto's thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol Jpn 40:459-468.
10. Astakhova LN, Anspaugh LR, Beebe G, et al. 1998. Chernobyl-related thyroid cancer in children of Belarus: A case-control study. Radiat Res 150:349-356.
11. Axelrod AA, Leblond CP. 1955. Induction of thyroid tumors in rats by a low iodine diet. Cancer 8:339-367.
12. Bacher-Stier C, Riccabona G, Totsch M, et al. 1997. Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7:733-741.
13. Balkany C, Cushing GW. 1995. An association between acromegaly and thyroid carcinoma. Thyroid 5:47-50.
14. Baloch ZW, Livolsi VA. 2001. Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma. Thyroid 11:637-645.
15. Ballivet S, Salmi LR, Dubourdieu D, et al. 1995. Incidence of thyroid cancer in New Caledonia, South Pacific, during 1985-1992. Am J Epidemiol 141:741-746.
16. Banu KS, Govindarajulu P, Aruldhas MM. 2001. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action. Endocr Pathol 12:315-327.
17. Baris D, Gridley G, Ron E, et al. 2002. Acromegaly and cancer risk: A linkage study in Sweden and Denmark. Cancer Causes Control 13:395-400.
18. Barnes ND. 1988. Effects of external irradiation on the thyroid gland in childhood. Horm Res 30:84-89.
19. Baverstock K, Egloff B, Pinchera A, et al. 1992. Thyroid cancer after Chernobyl. Nature 359:21-22.
20. Barzilay J, Heatley GJ, Cushing GW. 1991. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151:1629-1632.
21. BEIR. 1990 (Committee on the Biological Effects of Ionizing Radiations): Health effects of exposure to low levels of ionizing radiation (BEIR V). Washington, DC, National Academy Press.
22. Bernstein L, Miu A, Monroe K, et al. 1995. Cancer incidence among Filipinos in Los Angeles County, 1972-1991. Int J Cancer 63:345-348.
23. Birt DF, Pelling JC, Pour PM, et al. 1987. Enhanced pancreatic and skin tumorigenesis in cabbage-fed hamsters and mice. Carcinogenesis 8:913-917.
24. Block MA, Horn RC, Miller JM, et al. 1967. Familial medullary carcinoma of the thyroid. Ann Surg 166:403-411.
25. Blot WJ, Le Marchand L, Boice JD Jr., et al. 1997. Thyroid cancer in the Pacific. J Natl Cancer Inst 89:90-91.
26. Boice JD Jr, Engholm G, Kleinerman RA, et al. 1988. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116:3-55.
27. Bosetti C, Kolonel L, Negri E, et al. 2001. A pooled analysis of case-control studies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control 12:375-382.
28. Bosetti C, Negri E, Kolonel L, et al. 2002. A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International). Cancer Causes Control 13:765-775.
29. Bouville A, Simon SL, Miller CW, et al. 2002. Estimates of doses from global fallout. Health Phys 82:69-705.
30. Brandi ML, Gagel RF, Angeli A, et al. 2001. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671.
31. Breslow NE, Enstrom JE. 1974. Geographic correlations between cancer mortality rates and alcohol-tobacco consumption in the United States. JNCI 53:631-639.
32. Brinton LA, Melton J, Malkasian GD Jr, et al. 1989. Cancer risk after evaluation for infertility. Am J Epidemiol 129:712-722.
33. British Thyroid Association and the Royal College of Medicine. 2002. Guidelines for the Management of Thyroid Cancer in Adults. London: Royal College of Physicians.
34. Bross ID, Shimaoka K, Tidings J. 1971. Some epidemiological clues in thyroid cancer. Arch Intern Med 128:755-760.
35. Buglova EE, Kenigsberg JE, Sergeeva NV. 1996. Cancer risk estimation in Belarussian children due to thyroid irradiation as a consequence of the Chernobyl nuclear accident. Health Phys 71:45-49.
36. Bülow S, Holm NV, Mellamgaard A. 1988. Papillary thyroid carcinoma in Danish patients with familial adenomatous polyposis. Int J Colorect Dis 3:29-31.
37. Burgess JR. 2002. Temporal trends for thyroid carcinoma in Australia: An increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 12:141-149.
38. Burguera B, Gharib H. 2000. Thyroid incidentalomas-Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 29:187-203.
39. Camesslle-Teijeiro J and Chan JKC. 1999. Cribriform-morular variant of papillary carcinoma: A distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400-411.
40. Cardis E, Kesminiene A, Ivanov V, et al. 2005. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724-732.
41. Carstensen JM, Wingren G, Hatschek T, et al. 1990. Occupational risks of thyroid cancer: Data from the Swedish Cancer Environment Register, 1961-1979. Am J Ind Med 18:535-540.
42. Chen AY, Levy L, Goepfert H, et al. 2001. The development of breast carcinoma in women with thyroid carcinoma. Cancer 92:225-231.
43. Clark DE. 1955. Association of irradiation with cancer of the thyroid in children and adolescents. JAMA 159:1007-1009.
44. Cohen J, Xing MZ, Mambo E, et al. 2003. BRAF mutation in papillary thyroid carcinoma. J Nat Cancer Inst 95:625-627.
45. Coleman MP, Esteve J, Damiecki P, et al. 1993. Trends in cancer incidence and mortality. IARC, Publication No. 121. Lyon, France: International Agency for Research on Cancer, pp. 609-640.
46. Colonna M, Grosclaude P, Remontet L, et al. 2002. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 38:1762-1768.
47. Conard RA. 1984. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. In: Boice JD Jr., Fraumeni JF Jr., eds. Radiation Carcinogenesis: Epidemiology and Biological Significance. New York Raven Press, pp. 57-71.
48. Correa P, Chen VW. 1995. Endocrine gland cancer. Cancer 75:338-352.
49. Cotterill SJ, Pearce MS and Parker L. 2001. Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident? Eur J Cancer 37:1020-1026.
50. Crile G Jr, Hazard JB. 1962. Incidence of cancer in struma lymphomatosa. Surg Gynecol Obstet 115:101-103.
51. Dal Maso L, La Vecchia C, Franceschi S, et al. 2000. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 11:137-144.
52. D'Avanzo B, La Vecchia C, Franceschi S, et al. 1995. History of thyroid diseases and subsequent thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 4:193-199.
53. Davis S, Kopecky KJ, Hamilton TE, et al. 2004a. Thyroid neoplasia, auto-immune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. JAMA 292:2600-1613.
54. Davis S, Stepanenko V, Rivkind N, et al. 2004b. Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat Res 162:241-248.
55. de Vathaire F, Hardiman C, Shamsaldin A, et al. 1999. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 159:2713-2719.
56. de Vathaire F, Le VB, Vathaire CC. 2000. Thyroid cancer in French Polynesia between 1985 and 1995: Influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974. Cancer Causes Control 11:59-63.
57. DeGroot LJ, Reilly M, Pinnameneni K, et al. 1983. Retrospective and prospective study of radiation-induced thyroid disease. Am J Med 74:852-862.
58. Derwahl M, Broecker M, Karaiem Z. 1999. Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 84:829-834.
59. Dickman PW, Holm LE, Lundell G, et al. 2003. Thyroid cancer risk after thyroid examination with I131: A population-based cohort study in Sweden. Int J Cancer 106:580-587.
60. Divine BJ, Barron V. 1987. Texaco mortality study: III. A cohort study of producing and pipeline workers. Am J Ind Med 11:189-202.
61. Dobyns BM, Sheline GE, Workman JB, et al. 1974. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 38:976-998.
62. Doniach I. 1969. The thyroid: Epidemiology of thyroid cancer. J Roy Coll Surg Edinb 14:261-262.
63. Doniach I. 1971. Aetiological considerations of thyroid cancer. Br J Radiol 44:819.
64. Donis-Keller H, Dou S, Chi D, et al. 1993. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856.
65. Duffy BJ Jr, Fitzgerald PJ. 1950. Cancer of the thyroid in children: A report of 28 cases. J Clin Endocrinol Metab 10:1296-1308.
66. Eden K, Helfand M, Mahon S. 1999. Screening for thyroid cancer: background paper. In: National Research Council and Institute of Medicine, ed. Exposure of the American People to Iodine-131 From Nevada Nuclear-bomb Tests: Review of the National Cancer Institute Report and Public Health Implications. Washington DC: National Academy Press, pp. 221-263.
67. Eden K, Mahon S, Helfand M. 2001. Screening high-risk populations for thyroid cancer. Med Pediatr Oncol 36:583-591.
68. Fagin JA, Matsuo K, Karmarker A, et al. 1993. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-184.
69. Fagin JA. 1994. Molecular pathogenesis of human thyroid neoplasms. Thyroid Today 17:1-7.
70. Fahey TJ, Reeve TS, Delbridge L. 1995. Increasing incidence and changing presentation of thyroid cancer over a 30-year period. Br J surg 82:518-520.
71. Farid NR, Shi Y, Zou M. 1994. Molecular basis of thyroid cancer. Endocrine Rev 15:202-232.
72. Feldt-Rasmussen U. 2001. Iodine and cancer. Thyroid 11:483-486.
73. Fillmore CM, Petralia SA, Dosemeci M. 1999. Cancer mortality in women with probable exposure to silica: A death certificate study in 24 states of the U.S. Am J Ind Med 36:122-128.
74. Fincham SM, Ugnat AM, Hill GB, et al. 2000. Is occupation a risk factor for thyroid cancer? Canadian cancer registries epidemiology Research Group. J Occup Environ Med 42:318-322.
75. Franceschi S, Fassina A, Talamini R, et al. 1989. Risk factors for thyroid cancer in Northern-Italy. Int J Epidemiol 18:578-584.
76. Franceschi S, Fassina A, Talamini R, et al. 1990. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidemiol Santé Publique 38:27-34.
77. Franceschi S, La Vecchia C. 1994. Cancer of the thyroid. In: Doll R, Fraumeni JF Jr., Muir CS, eds. Trends in cancer incidence and mortality. Vol. 19/20. Cold Spring Harbor: Cold Spring Harbor Press, pp. 393-424.
78. Franceschi S, Levi F, Negri E, et al. 1991. Diet and thyroid cancer: A pooled analysis of four European case-control studies. Int J Cancer 48:395-398.
79. Franceschi S, Preston-Martin S, Dal Maso L, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 10:583-595.
80. Franceschi S. 1998. Iodine intake and thyroid carcinoma-a potential risk factor. Exp Clin Endocrinol Diabetes 106(suppl 3):38-44.
81. Franklyn JA, Maisonneuve P, Sheppard M, et al. 1999. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study. Lancet 353:2111-2115.
82. Franklyn JA, Maisonneuve P, Sheppard MC, et al. 1998. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338:712-718.
83. Franssila K, Saxén E, Teppo L, et al. 1981. Incidence of different morphological types of thyroid cancer in the Nordic countries. Acta Pathol Microbiol Scand 89:49-55.
84. Franssila KO, Harach HR. 1986. Occult papillary carcinoma of the thyroid in children and young adults: A systemic autopsy study in Finland. Cancer 58:715-719.
85. Frentzel-Beyme R, Helmert U. 2000. Association between malignant tumors of the thyroid gland and exposure to environmental protective and risk factors. Rev Environ Health 15:337-358.
86. Friedman G, Ury HK. 1980. Initial screening for carcinogenicity of commonly used drugs. JNCI 65:723-733.
87. Friedman GD, Ury HK. 1983. Screening for possible drug carcinogenicity: Second report of findings. JNCI 71:1165-1175.
88. From G, Mellemgaard A, Knudsen N, et al. 2000. Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid 10:697-700.
89. Fukunaga FH, Lockett LJ. 1971. Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol 92:6-13.
90. Fukunaga FH, Yatani R. 1975. Geographic pathology of occult thyroid carcinomas. Cancer 36:1095-1099.
91. Gaitan E. 1997. Environmental goitrogens. In: Braverman LE, ed. Diseases of the Thyroid. Totowa, New Jersey: Humana Press, pp. 331-348.
92. Galanti MR, Ekbom A, Grimelius L, et al. 1997. Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 75:451-456.
93. Galanti MR, Lambe M, Ekbom A, et al. 1995. Parity and risk of thyroid cancers: A nested case-control study of a nationwide Swedish cohort. Cancer Causes Control 6:37-44.
94. Gembicki M, Stozharov AN, Arinchin AN, et al. 1997. Iodine deficiency in Belarusian children as a possible factor stimulating the irradiation of the thyroid gland during the Chernobyl catastrophe. Environ Health Perspect 105:1487-1490.
95. Gharib H, Goellner JR. 1993. Fine-needle aspiration biopsy of the thyroid-An appraisal. Ann Intern Med 118:282-289.
96. Gilbert ES, Tarone R, Bouville A, et al. 1998. Thyroid cancer rates and I-131 doses from Nevada atmospheric nuclear bomb tests. J Natl Cancer Inst 90:1654-1660.
97. Gilliland FD, Hunt WC, Morris DM, et al. 1997. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573.
98. Glattre E, Thomassen Y, Thoresen SØ, et al. 1989. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 18:45-49.
99. Glöbel B, Glöbel H, Oberhausen E. 1984. Epidemiologic studies on patients with iodine-131 diagnostic and therapy. In: Kaul A, Neider R, Pensko J, et al., eds. Radiation-risk-protection, vol II. International Radiation Protection Association. Köln: Fachverband für Strahlenschutz e.V., 565-568.
100. Goldgar DE, Easton DF, Cannon-Albright LA et al. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
101. Goodman MT, Yoshizawa CN, Kolonel LN. 1988. Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 61:1272-1281.
102. Greene MH, Wilson J. 1985. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:191-218.
103. Greenwald P, Korns RF, Nasca PC, et al. 1975. Cancer in United States Jews. Cancer Res 35:3507-3512.
104. Gross C, Yu M, Van Herle AJ, et al. 1993. Presence of a specific antiestrogen binding site on human follicular thyroid carcinoma cell line (UCLA RO 82 W-1): Inhibition by an endogenous ligand present in human serum. J Clin Endocrinol Metab 77:1361-1366.
105. Grossman RF, Tu SH, Duh QY, et al. 1995. Familial nonmedullary thyroid cancer: An emerging entity that warrants aggressive treatment. Arch Surg 130:892-899.
106. Hahn K, Schnell-Inderst P, Grosche B, et al. 2001. Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat Res 156:61-70.
107. Hall P, Berg G, Bjelkengren G, et al. 1992. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 50:886-890.
108. Hall P, Holm L-E, Lundell G. 1990. Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol 29:869-873.
109. Hallquist A, Hardell L, Degerman A, et al. 1993. Occupational exposures and thyroid cancer: Results of a case-control study. Eur J Cancer Prev 2:345-349.
110. Hallquist A, Hardell L, Degerman A, et al. 1994. Thyroid cancer: Reproductive factors, previous thyroid diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev 3:481.
111. Hamilton TE, van Belle G, LoGerfo JP. 1987. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. JAMA 258:629-636.
112. Hancock SL, Cox RS, McDougall IE. 1991. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599-605.
113. Harach HR, Escalante DA, Day ES. 2002. Thyroid cancer and thyroiditis in Salta, Argentina: A 40-yr study in relation to iodine prophylaxis. Endocr Pathol 13:175-181.
114. Harach HR, Franssila KO, Wasenius V-M. 1985. Occult papillary carcinoma of the thyroid. Cancer 56:531-538.
115. Hard GC. 1998. Recent developments in the investigation of thyroid regulation a thyroid carcinogenesis. Environ Health Perspect 106:427-436.
116. Harvey EB, Brinton LA. 1985. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112.
117. Haselkorn T, Bernstein L, Preston-Martin S, et al. 2000. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control 11:163-170.
118. Haselkorn T, Stewart SL, Horn-Ross PL. 2003. Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 12:144-150.
119. Hatch M, Ron E, Bouville A, et al. 2005. Cancer following the accident at the Chernobyl nuclear power plant. Epidemiol Rev 27:56-66.
120. Hedinger C, Williams ED, Sobin LH. 1988. Histological Typing of Thyroid Tumours. 2nd ed. International Histological Classification of Tumours. World Health Organization. No. 11. Berlin, Springer-Verlag.
121. Hedinger C, Williams ED, Sobin LH. 1989. The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer 63:908-911.
122. Hegedus L. 2001. Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339-360.
123. Heitz P, Moser H, Staub JJ. 1976. Thyroid cancer: A study of 573 thyroid tumors and 161 autopsy cases observed over a thirty-year period. Cancer 37:2329-2337.
124. Hemminki K, Dong C. 2000. Familial relationships in thyroid cancer by histopathological type. Int J Cancer 85:201-205.
125. Hemminki K, Jiang Y. 2001. Second primary neoplasms after 19281 endocrine gland tumors: Aetiological links? Eur J Cancer 37:1886-1894.
126. Hempelmann LH, Furth J. 1978. Etiology of thyroid cancer. In: Greenfield LD, ed. Thyroid cancer. West Palm Beach, FL: CRC Press, pp. 37-49.
127. Hempelmann LH, Hall WJ, Phillips M, et al. 1975. Neoplasms in persons treated with x-rays in infancy: Fourth survey in 20 years. JNCI 55:519-530.
128. Henderson BE, Kolonel LN, Dworsky R, et al. 1985. Cancer incidence in the islands of the Pacific. Natl Cancer Inst Monogr 69:73-81.
129. Henderson BE, Ross RK, Pike MC, et al. 1982. Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232-3239.
130. Hill RN, Crisp TM, Hurley PM, et al. 1998. Risk assessment of thyroid follicular cell tumors. Environ Health Perspect 106:447-457.
131. Hizawa K, Iida M, Aoyagi K et al. 1997. Thyroid neoplasia and familial adenomatous polyposis/Gardner's syndrome. J Gastroenterol 32:196-199.
132. Hofmann C, Oslapas R, Nayyar R, et al. 1986. Testosterone enhancement of thyroid carcinoma in rats: The role of TSH. Surgery 100:1078-1085.
133. Hofstra RM, Landsvater RM, Ceccherini I. 1994. A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376.
134. Hollowell JG, Staehling NW, Flanders WD, et al. 2002. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
135. Holm L-E, Blomgren H, Löwhagen T. 1985. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312:601-604.
136. Holm L-E, Hall P, Wiklund KE, et al. 1991. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83:1072-1077.
137. Holm L-E, Wiklund KE, Lundell GE, et al. 1988. Thyroid cancer after diagnostic doses of Iodine-131: A retrospective cohort study. J Natl Cancer Inst 80:1132-1138.
138. Horn-Ross PL, Hoggatt KJ, Lee MM. 2002. Phytoestrogens and thyroid cancer risk: The San Francisco Bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 11:43-49.
139. Horn-Ross PL, Morris JS, Lee M, et al. 2001. Iodine and thyroid cancer risk among women in a multiethnic population: The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 10:979-985.
140. Howe HL, Wingo PA, Thun MJ. 2001. Annual report to the Nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824-842.
141. Huszno B, Szybinski Z, Przybylik-Mazurek E, et al. 2003. Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area. J Endocrinol Invest 26(suppl 2):71-76.
142. Inskip PD, Hartshorne MF, Tekkel M, et al. 1997. Thyroid nodularity and cancer among Chernobyl cleanup workers from Estonia. Radiat Res 147:225-235.
143. Inskip PD. 2001. Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol 36:568-573.
144. Iribarren C, Haselkorn T, Tekawa IS, et al. 2001. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 93:745-750.
145. Isler H. 1959. Effect of iodine on thyroid tumors induced in the rat by a lowiodine diet. J Natl Cancer Inst 23:675-693.
146. Ito T, Seyama T, Mizuno T, et al. 1992. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 52:1369-1371.
147. Ivanov V, Gorski A, Maksyutov M, et al. 2003. Thyroid cancer incidence among adolescents and adults in Bryansk region of Russia following Chernobyl accident. Health Phys 84:46-60.
148. Ivanov VK, Tsyb AF, Petrov AV, et al. 2002. Thyroid cancer incidence among liquidators of the Chernobyl accident: Absence of dependence of radiation risks on external radiation dose. Radiat Environ Biophys 41:195-198.
149. Ivanov VK, Tsyb AF, Gorsky AI, et al. 2004. Radiological health effects of the Chernobyl accident: Estimation of radiation risks. IRPA 11 Madrid.
150. Iwasa Z, Jinnai D, Koyama H, et al. 1986. Second primary cancer following adjuvant chemotherapy, radiotherapy and endocrine therapy for breast cancer: A nationwide survey on 47,005 Japanese patients who underwent mastectomy from 1963-1982. Jpn J Surg 16:262-271.
151. Jackson CE, Block MA, Greenwald KA, et al. 1979. The two mutational-event theory in modelling thyroid cancer. Am J Hum Genet 31:704-710.
152. Jacob P, Bogdanova TI, Buglova EE, et al. 2002. Comparison of thyroid cancer incidence after the Chernobyl accident in Belarus and Ukraine. In: Yamashita S, Shibata M, Hoshi K, et al., eds. Chernobyl: Message for the 21st Century. Amsterdam: Elsevier, pp. 215-220.
153. Jacob P, Kenigsberg Y, Zvonova I, et al. 1999. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 80:1461-1469.
154. Jemal A, Murray T, Samuels A, et al. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
155. Jemal A, Tiwari RC, Murray T, et al. 2004. Cancer statistics, 2004. CA Cancer J Clin 54:8-29.
156. Jhiang SM, Sagartz JE, Tong Q, et al. 1996. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378.
157. Kalk WJ, Sitas F, Patterson AC. 1997. Thyroid cancer in South Africa-an indicator of regional iodine deficiency. S Afr Med J 87:735-738.
158. Kameyama K, Mukai, M. 2004. Cribriform-morular variant of papillary carcinoma: Ultrastructural study and somatic/germline mutation analysis of the APC gene. Ultrastructural Pathol 28:97-102.
159. Kanno J, Matsuoka C, Furuta K, et al. 1990. Tumor promoting effect of goitrogens on the rat thyroid. Toxicol Pathol 18:239-246.
160. Kaplan L, Katz AD, Ben-Isaac C, et al. 1971. Malignant neoplasms and parathyroid adenoma. Cancer 28:401-407.
161. Karga H, Lee J-K, Vickery AL, et al. 1991. Ras oncogene mutations in benign and malinant thyroid tumors. J Clin Endocrinol Metab 73:832-836.
162. Kazakov VS, Demidchik EP, Astakhova LN. 1992. Thyroid cancer after Chernobyl. Nature 359:21.
163. Kenigsberg J, Buglova E, Kruk J, et al. 2002. Thyroid cancer among children and adolescents of Belarus exposed due to the Chernobyl accident: dose and risk assessment. In: Yamashita S, Shibata Y, Hoshi M, Fujimura K, eds. Chernobyl: Message for the 21st Century. International Congress Series 1234, pp. 293-300.
164. Kerber RA, Till JE, Simon SL, et al. 1993. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270:2076-2082.
165. Kimura ET, Nikiforova MN, Zhu Z, et al. 2003. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457.
166. Klugbauer S, Pfeiffer P, Gassenhuber H, et al. 2001. RET rearrangements in radiation-induced papillary thyroid carcinomas: High prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes. Genomics 73:149-160.
167. Kolonel LN, Hankin JH, Wilkens LR, et al. 1990. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1:223-234.
168. Kopecky KJ, Davis S, Hamilton TE, et al. 2004. Estimation of thyroid radiation doses for the hanford thyroid disease study: results and implications for statistical power of the epidemiological analyses. Health Phys 87:15-32.
169. Kowalski LP, Goncalves Filho J, Pinto CA, et al. 2003. Long-term survival rates in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129:746-749.
170. Krassas GE. 2000. Thyroid disease and female reproduction. Fertil Steril 74:1063-1070.
171. Kravdal Ø, Glattre E, Haldorsen T. 1991. Positive correlation between parity and incidence of thyroid cancer: New evidence based on complete Norwegian birth cohorts. Int J Cancer 49:831-836.
172. Kreiger N, Parkes R. 2000. Cigarette smoking and the risk of thyroid cancer. Eur J Cancer 36:1969-1973.
173. Kroll TG. 2002. Molecular rearrangements and morphology in thyroid cancer. Am J Pathol 160:1941-1944.
174. Kroll TG, Sarraf P, Pecciarini L, Chen, et al. 2000. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289(5483):1357-1360.
175. La Vecchia C, Lucchini F, Negri E, et al. 1992. Trends of cancer mortality in Europe, 1955-1989: IV, urinary tract, eye, brain and nerves, and thyroid. Eur J Cancer 28A: 1210-1281.
176. La Vecchia C, Ron E, Franceschi S, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157-166.
177. Lee SH, Kim KM, Jung BH, et al. 2003. Estrogens in female thyroid cancer: Alteration of urinary profiles in pre-and post-operative cases. Cancer Lett 189:27-32.
178. Lee W, Chiacchierini RP, Shleien B, et al. 1982. Thyroid tumors following 131I or localized X irradiation to the thyroid and pituitary glands in rats. Radiat Res 92:307-319.
179. Le Marchand L, Hankin J, Bach F, et al. 1995. An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 63:18-23.
180. Lemoine NR, Mayall ES, Wyllie FS, et al. 1988. Activated ras oncogenes in human cancers. Cancer Res 48:4459-4463.
181. Lemoine NR, Mayall ES, Wyllie FS, et al. 1999. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159-164.
182. Levi F, Franceschi S, Gulie C, Negri E, et al. 1993. Female thyroid cancer: The role of reproductive and hormonal factors in Switzerland. Oncology 50:309-315.
183. Levi F, Franceschi S, La Vecchia C, et al. 1991. Previous thyroid disease and risk of thyroid cancer in Switzerland. Eur J Cancer 27:85-88.
184. Levi F, Franceschi S, Te VC, et al. 1990. Descriptive epidemiology of thyroid cancer in the Swiss canton of Vaud. J Cancer Res Clin Oncol 116:639-647.
185. Levi F, Lucchini F, Negri E, et al. 1999. Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994. Eur J Cancer 35:1477-1516.
186. Likhtarov I, Kovgan S, Vavilov M, et al. 2005. Post-Chornobyl thyroid cancers in Ukraine. Report 1: Estimation of thyroid doses. Radiat Res 163:125-136.
187. Likhtarev IA, Chumack VV, Repin VS. 1994. Retrospective reconstruction of individual and collective external gamma doses of population evacuated after the Chernobyl accident. Health Phys 66:643-652.
188. Likhtarev IA, Sobolev BG, Kairo IA, et al. 1995. Thyroid cancer in the Ukraine. Nature 375:365.
189. Lind P, Kumnig G, Heinisch M, et al. 2002. Iodine supplementation in Austria: methods and results. Thyroid 12:903-907.
190. Lind P, Langsteger W, Molnar M. 1998. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8:1179-1183.
191. Linos A, Linos DA, Vgotza N, et al. 1989. Does coffee consumption protect against thyroid disease? Acta Chir Scand 155:317-320.
192. Lips CJM, Landsvaater RM, Höppener JWM, et al. 1994. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331:828-835.
193. Liu S, Semenciw R, Ugnat AM, et al. 2001. Increasing thyroid cancer incidence in Canada, 1970-1996: Time trends and age-period-cohort effects. Br J Cancer 85:1335-1339.
194. LiVolsi VA, Asa SL. 1994. The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233-236.
195. LiVolsi VA, Feind CR. 1976. Parathyroid adenoma and non-medullary thyroid carcinoma. Cancer 38:1391-1393.
196. Lund E, Galanti MR. 1999. Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: An analysis of birth cohorts. Cancer Causes Control 10:181-187.
197. Lundell M, Hakulinen T, Holm L-E. 1994. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 140:334-339.
198. Lundgren CI, Hall P, Ekbom A, et al. 2003. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 106:569-573.
199. Lupoli G, Vitale G, Caraglia M, et al. 1999. Familial papillary thyroid microcarcinoma: A new clinical entity. Lancet 353:637-639.
200. Maceri DR, Sullivan MJ, McClatchney KD. 1986. Autoimmune thyroiditis: Pathophysiology and relationship to thyroid cancer. Laryngoscope 96:82-86.
201. Mack WJ, Preston-Martin S, Bernstein L, et al. 1999. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 8:991-997.
202. Mack WJ, Preston-Martin S, Dal Maso L, et al. 2003. A pooled analysis of case-control studies of thyroid cancer: Cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 14:773-785.
203. Malkasian GD, Mayberry WE. 1970. Serum total and free thyroxine and thyrotropin in normal and pregnant women, neonates, and women receiving progestogens. Am J Obstet Gynec 108:1234-1238.
204. Mangano JJ. 1996. A post-Chernobyl rise in thyroid cancer in Connecticut, USA. Eur J Cancer Prev 5:75-81.
205. Manole D, Schildknecht B, Gosnell B, et al. 2001. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86:1072-1077.
206. Mazzaferri EL, Jhiang SM. 1994. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
207. McIver B, Eberhardt NL. 2002. Cowden disease and the PTEN/MMAC1 gene. Genetics of Complex Thyroid Diseases. 151-175.
208. McTiernan AM, Weiss NS, Daling JR. 1984b. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 120:423-435.
209. Mellemgaard A, From G, Jorgensen T et al. 1998. Cancer risk in individuals with benign thyroid disorders. Thyroid 8:751-754.
210. Memon A, Darif M, Al Saleh K, et al. 2002. Epidemiology of reproductive and hormonal factors in thyroid cancer: Evidence from a case-control study in the Middle East. Int J Cancer 97:82-89.
211. Memon A, Varghese A, Suresh A. 2002. Benign thyroid disease and dietary factors in thyroid cancer: A case-control study in Kuwait. Br J Cancer 86:1745-1750.
212. Mishra SI, Luce-Aoelua PH, Wilkens LR. 1996. Cancer among indigenous populations. The experience of American Samoans. Cancer 78:1553-1557.
213. Modan B, Ron E, Lerner-Geva L, et al. 1998. Cancer incidence in a cohort of infertile women. Am J Epidemiol 147:1038-1042.
214. Moysich K, Menezes R, Michalek A. 2002. Chernobyl-related ionising radiation exposure and cancer risk: An epidemiological review. Lancet Oncol 5:269-279.
215. Mulla ZD, Margo CE. 2000. Primary malignancies of the thyroid: epidemiologic analysis of the Florida cancer data system registry. Ann Epidemiol 10:24-30.
216. Mulligan LM, Kwok JBJ, Healey CS, et al. 1993. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
217. Namba H, Rubin SA, Fagin JA. Point mutations of ras oncoenes are an early event in thyroid tumorigenesis. Mol Endocrinol 4:1474-1479.
218. Narita T, Takagi K. 1984. Ataxia-telangiectasia with dysgerminoma of right ovary, papillary carcinoma of thyroid, and adenocarcinoma of pancreas. Cancer 54:1113-1116.
219. NAS (National Academy of Sciences). 2000. Review of the Hanford thyroid disease study draft final report. Washington, DC: National Academy Press.
220. NCRP (National Council on Radiation Protection and Measurement). 1985. Induction of thyroid cancer by ionizing radiation. Report No. 80. Bethesda, MD: NCRP.
221. Negri E, Dal Maso L, Ron E, et al. 1999b. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10:143-155.
222. Negri E, La Vecchia C, Franceschi S, et al. 1991. Vegetable and fruit consumption and cancer risk. Int J Cancer 48:350-354.
223. Negri E, Ron E, Franceschi S, et al. 1999a. A pooled analysis of case-control studies of thyroid cancer-I. Methods. Cancer Causes Control 10:131-142.
224. Nmec J, Zamrazil V, Pohunková D, et al. 1980. Thyroidectomy as a pathogenic factor in the evolution of thyroid cancer. Neoplasma 27:595-599.
225. Ng SB, Sittampalam K, Goh YH, et al. 2003. Cribriform-morular variant of papillary carcinoma: The sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation. Pathology 35:42-46.
226. Nikiforov YE, Koshoffer A, Nikiforova M, et al. 1999. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene 18:6330-6334.
227. Nikiforov YE, Rowland JM, Bove KE, et al. 1997. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57:1690-1694.
228. Nikiforova MN, Lynch RA, Biddinger PW, et al. 2003. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: Evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326.
229. Nikiforova MN, Stringer JB, Blough R, et al. 2000. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290:138-141.
230. Ohshima M, Ward JM. 1986. Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCR rats. Cancer Res 46:877-883.
231. Ohta S, Katsura T, Shimada M, et al. 1986. Ataxia-telangiectasia with papillary carcinoma of the thyroid. Am J Pediatr Hemat/Oncol 8:255-268.
232. Oliynyk V, Epshtein O, Sovenko T, et al. 2001. Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer. J Endocrinol Invest 24:445-447.
233. Olsen JH, Boice JD Jr., Jensen JPA, et al. 1989. Cancer among epileptics exposed to anti-convulsant drugs. J Natl Cancer Inst 81:803-808.
234. Ottino A, Pianzola HM, Castelletto RH. 1989. Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer 64:547-551.
235. Ozaki O, Ito K, Kobayashi K, et al. 1988. Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World J Surg 12:565-571.
236. Pacchiarotti A, Martino E, Bartalena L, et al. 1986. Serum thyrotropin by ultra-sensitive immunoradiometric assay and serum free thyroid hormones in pregnancy. J Endocrinol Invest 9:185-189.
237. Paksoy N, Bouchardy C, Parkin DM. 1991. Cancer incidence in Western Samoa. Int J Epidemiol 20:634-641.
238. Paksoy N, Montaville B, McCarthy SW. 1990. Cancer occurrence in Vanuatu in the South Pacific, 1980-86. Trop Geogr Med 42:157-161.
239. Pal T, Vogl FD, Chappuis PO, et al. 2001. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of non-medullary thyroid cancer: A hospital-based study. J Clin Endocrinol Metab 86:5307-5312.
240. Paloyan E, Hofmann C, Prinz R, et al. 1982. Castration induces a marked reduction in the incidence of thyroid cancers. Surgery 92:839-848.
241. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. 2002a. Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications No. 153. Lyon, France: International Agency for Research on Cancer.
242. Parkin DM, Pisani P, Ferlay J. 1999. Global cancer statistics. CA Cancer Clin 49:33-64.
243. Parkin DM, Whelan SL, Ferlay J, et al. 2002b. Cancer Incidence in Five Continents Vol. VIII. Lyon, France: IARC Scientific Publications.
244. Paynter OE, Burin GJ, Jaeger RB, et al. 1988. Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process. Regul Toxicol Pharmocol 8:102-119.
245. Pettersson B, Coleman MP, Ron E, et al. 1996. Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 65:13-19.
246. Picchi P, Faloci C, Salabe GB. 2001. Reproductive history, contraceptives and cigarette smoke as risk factors for cancer of the thyroid in women. Case-control study. Minerva Endocrinol 26:53-57.
247. Pickle LW, Mason TJ, Howard N, et al. 1987. Atlas of U.S. mortality among whites: 1930-1980. Washington, DC: NIH Publication No. 87-2900, US Govt. Printing Office.
248. Pillaj NK, Thangavelu M, Ramalingaswami V. 1976. Nodular lesions of the thyroid in an area of high background radiation in coastal Kerala, India. Indian J Med Res 64:537-544.
249. Plail RO, Bussey HJR, Glazer G, et al. 1987. Adenomatous polyposis: An association with carcinoma of the thyroid. Br J Surg 74:377-380.
250. Poth M. 2000. Thyroid cancer in children and adolescents, in L Wartofsky "Thyroid Cancer: A Comprehensive Guide to Clinical Management". Totowa, New Jersey: Humana Press, pp. 121-128.
251. Pottern LM, Kaplan MM, Larsen PR, et al. 1990. Thyroid nodularity after irradiation for lymphoid hyperplasia: A comparison of questionnaire and clinical findings. J Clin Epidemiol 43:449-460.
252. Pottern LM, Stone BJ, Day NE, et al. 1980. Thyroid cancer in Connecticut, 1935-1975: An analysis by cell type. Am J Epidemiol 112:764-774.
253. Preston-Martin S, Bernstein L, Pike MC, et al. 1987. Thyroid cancer among young women related to prior thyroid disease. Br J Cancer 55:191-195.
254. Preston-Martin S, Franceschi S, Ron E, et al. 2003. Thyroid cancer pooled analysis from 14 case-control studies: What have we learned? Cancer Causes Control 14:787-790.
255. Preston-Martin S, Jin F, Duda MJ, et al. 1993. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 4:431-440.
256. Preston-Martin S, Menck HR. 1979. The epidemiology of thyroid cancer in Los Angeles County. West J Med 131:369-372.
257. Prisyazhiuk A, Pjatak OA, Buzanov VA, et al. 1991. Cancer in the Ukraine, post-Chernobyl. Lancet 338:1334-1335.
258. Reiners C, Biko J, Demidchik EP, et al. 2002. Results of radioactive iodine treatment in children from Belarus with advanced stages of thyroid cancer after the Chernobyl accident. Chernobyl: Message for the 21st Century. 205-214.
259. Remontet L, Esteve J, Bouvier AM, et al. 2003. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51(1 Pt 1):3-30.
260. Ries LAG, Eisner MP, Kosary CL, et al., eds. 2004. SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD. Available at:
261. Ries LAG, Miller BA, Hankey BF, et al., eds. 1994. SEER cancer statistics review, 1973-1991: Tables and graphs. NIH publ. no. 94-2789, Bethesda, MD: National Cancer Institute.
262. Robbins J, Adams WH. 1989. Radiation effects in the Marshall Islands. In: Nagataki S, ed. Radiation and the Thyroid. Amsterdam: Excerpta Medica, pp. 11-24.
263. Ron E, Curtis R, Hoffman DA, et al. 1984. Multiple primary breast and thyroid cancer. Br J Cancer 49:87-92.
264. Ron E, Doody MM, Becker D, et al. 1998. Cancer mortality following treatment for hyperthyroidism. JAMA 280:347-355.
265. Ron E, Kleinerman RA, Boice JD Jr., et al. 1987. A population-based case-control study of thyroid cancer. JNCI 79:1-12.
266. Ron E, Kleinerman RA, LiVolsi VA, et al. 1991. Familial nonmedullary thyroid cancer. Oncology 48:309-311.
267. Ron E, Lubin JH, Shore RE, et al. 1995. Thyroid cancer following exposure to external radiation: A pooled analysis of seven studies. Radiat Res 141:255-273.
268. Ron E, Modan B, Preston D, et al. 1989. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 120:516-531.
269. Ronckers CM, McCarron P, Ron E. 2005. Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117:281-288.
270. Rossing MA, Cushing KL, Voigt LF, et al. 2000. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 11:49-54.
271. Rossing MA, Schwartz SM, Weiss NS. 1995. Thyroid cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 6:439-444.
272. Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR. 1998. Use of exogenous hormones and risk of papillary thyroid cancer (Washington, United States). Cancer Causes Control 9:341-349.
273. Rubino C, Cailleux AF, de Vathaire F, et al. 2002. Thyroid cancer after radiation exposure. Eur J Cancer 38:645-647.
274. Rubino C, de Vathaire F, Dottorini ME, et al. 2003. Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638-1644.
275. Ryo UY, Arnold J, Colman M, et al. 1976. Thyroid scintigram. Sensitivity with sodium pertechnetate tc 99 gamma camera with pinhole collimator. JAMA 235:1235-1238.
276. Sadetzki S, Calderon-Margalit R, Peretz C, et al. 2003. Second primary breast and thyroid cancers (Israel). Cancer Causes Control 14:367-375.
277. Sakoda LC, Horn-Ross PL. 2002. Reproductive and menstrual history and papillary thyroid cancer risk: The San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 11:51-57.
278. Samaan N, Schultz P, Ordonez N, et al. 1987. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 64:219-223.
279. Sampson RJ, Woolner LB, Bahn RC, et al. 1974. Occult thyroid carcinoma in Olmstead County, Minnesota. Prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 34:2072-2076.
280. Schenker JC, Levinsky R, Ohel G. 1984. Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer 54:145-150.
281. Schneider AB, Recant W, Pinsky S, et al. 1986b. Radiation-induced thyroid carcinoma: Clinical course and results of therapy in 298 patients. Ann Intern Med 105:405-412.
282. Schneider AB, Bekerman C, Leland J, et al. 1997. Thyroid nodules in the follow-up of irradiated individuals: Comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 82:4020-4027.
283. Schneider AB, Pinsky S, Bekerman C, et al. 1980. Characteristics of 108 thyroid cancers detected by screening in a population with a history of head and neck irradiation. Cancer 46:1218-1227.
284. Schneider AB, Ron E, Lubin J, et al. 1993. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 77:362-369.
285. Schneider AB, Shore-Freedman E, Ryo UY, et al. 1985. Radiation-induced tumors of the head and neck following childhood irradiation. Medicine 64:1-15.
286. Schneider AB, Shore-Freedman E, Weinstein RA. 1986a. Radiation-induced thyroid and other head and neck tumors: Occurrence of multiple tumors and analysis of risk factors. J Clin Endocrinol Metab 63:107-112.
287. Schottenfeld D, Berg JW. 1971. Incidence of multiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst 46:161.
288. Segev DL, Umbricht C, Zeiger MA. 2003. Molecular pathogenesis of thyroid cancer. Surg Oncol 12:69-90.
289. Selby JV, Friedman GD, Fireman BH. 1989. Screening prescription drugs for possible carcinogenicity: Eleven to fifteen years of follow-up. Cancer Res 49:5736-5747.
290. Shakhtarin VV, Tsyb AF, Stepanenko VF, et al. 2003. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 32:584-591.
291. Shi Y, Zou M, Schmidt H, et al. 1991. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res 51:2690-2693.
292. Shibata Y, Yamashita S, Masyakin V, et al. 2001. 15 years after Chernobyl: New evidence of thyroid cancer. Lancet 358:1965-1966.
293. Simon MS, Tang MT, Bernstein L, et al. 2002. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 11:1574-1578.
294. Shore RE. 1992. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 131:98-111.
295. Shore RE, Hempelmann LH, Woodward ED. 1986. Carcinogenic effects of radiation on the human thyroid gland. In: Upton AC, Albert RE, Burns FJ, et al., eds. Radiation Carcinogenesis. New York: Elsevier, pp. 293-310.
296. Shore RE, Hildreth N, Dvoretsky E, et al. 1993. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 137:1068-1080.
297. Shore RE, Woodard E, Hildreth N, et al. 1985. Thyroid tumors following thymus irradiation. JNCI 74:1177-1184.
298. Shore RE, Xue X-N. 1999. Comparative thyroid cancer risk of childhood and adult radiation exposure and estimation of lifetime risk. In: Thomas D, Karaoglou A, Williams ED, eds. Radiation and Thyroid Cancer. Singapore, World Scientific Publishing, pp. 491-498.
299. Siegal A, Modan M. 1981. Latent carcinoma of thyroid in Israel: a study of 260 autopsies. Isr J Med Sci 17:249-253.
300. Sigurdson AJ, Doody MM, Rao RS, et al. 2003. Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 15:3080-3089.
301. Sigurdson AJ, Ronckers CM, Mertens AC, et al. 2005. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365:2014-2023.
302. Silverberg SG, Vidone RA. 1966. Carcinoma of the thyroid in surgical and postmortem material. Analysis of 300 cases at autopsy and literature review. Ann Surg 164:291-299.
303. Simon MS, Tang MT, Bernstein L, et al. 2002. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 12:684-685.
304. Sokic SI, Adanja BJ, Vlajinac HD, et al. 1994. Risk factors for thyroid cancer. Neoplasma 41:371-374.
305. Steinmetz KA, Potter JD. 1996. Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc 96:1027-1039.
306. Stepanenko VF, Voilleque PG, Gavrilin YI, et al. 2004. Estimating individual thyroid doses for a case-control study of childhood thyroid cancer in Bryansk Oblast, Russia. Radiat Prot Dosimetry 108:1431-1460.
307. Stezhko VA, Buglova EE, Danilova LI, et al. 2004. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methods. Radiat Res 161:481-492.
308. Stoffer SS, Van Dyke DL, Bach JV, et al. 1986. Familial papillary carcinoma of the thyroid. Am J Med Genet 25:775-782.
309. Stsjazhko VA, Tsyb AF, Tronko ND, et al. 1995. Childhood thyroid cancer since accident at Chernobyl. Br Med J 310:801.
310. Suárez HG, du Villard JA, Severino M, et al. 1990. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene 5:565-570.
311. Szybinski Z, Huszno B, Zemla B, et al. 2003. Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest 26:63-70.
312. Takagi H, Mitsumori K, Onodera H, et al. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats. Cancer Lett 178:1-9.
313. Takahashi T, Schoemaker MJ, Trott KR, et al. 2003. The relationship of thyroid cancer with radiation exposure from nuclear weapon testing in the Marshall Islands. J Epidemiol 13:99-107.
314. Takeichi N, Ito H, Haruta R, et al. 1991. Relation between estrogen receptor and malignancy of thyroid cancer. Jpn J Cancer Res 82:19-22.
315. Takezaki T, Hirose K, Inoue M, et al. 1996. Risk factors of thyroid cancer among women in Tokai, Japan. J Epidemiol 6:140-147.
316. Tanaka K, Sonoo H, Yamamoto Y, et al. 1999. Analyses of the outcome of locally invasive papillary thyroid carcinomas. Thyroid 9:1017-1022.
317. Teppo L, Pukkala E, Saxén E. 1985. Multiple cancer-an epidemiologic exercise in Finland. JNCI 75:207-217.
318. Thomas GA, Bunnell H, Cook HA, et al. 1999. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84:4232-4238.
319. Thompson D, Mabuchi K, Ron E, et al. 1994. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-87. Radiat Res 137:S17-S67.
320. Trapido EJ, McCoy CB, Stein NS, et al. 1990. The epidemiology of cancer among Hispanic women. Cancer 66:2435-2441.
321. Tronko M, Bogdanova T, Komissarenko I, et al. 1999. Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: Statistical data and clinicomorphologic characteristics. Cancer 86:149-156.
322. Tronko M, Bogdanova T, Komissarenko I, et al. 1996. Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident (1986-1995). In: Karaoglou A, Desmet G, Kelly GN, et al., eds. The Radiological Consequences of the Chernobyl Accident. Luxembourg: EUR 16544 EN, pp. 683-690.
323. Tucker MA, Morris Jones PH, Boice JD Jr., et al. 1991. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51:2885-2888.
324. Turrin A, Pilotti S, Ricci SB. 1985. Characteristics of thyroid cancer following irradiation. Int J Radiat Oncol Biol Phys 11:2149-2154.
325. UNSCEAR (United Nations Scientific Committee on the Effects of Radiation). 2000. Sources and effects of ionizing radiation. New York: United Nations.
326. Utiger RD. 1995. Cigarette smoking and the thyroid. N Engl J Med 333:1001-1002.
327. Utiger RD. 1994. Medullary thyroid carcinoma, genes, and the prevention of cancer. N Engl J Med 331:870-871.
328. Vågerö D, Persson G. 1986. Occurrence of cancer in socioeconomic groups in Sweden. An analysis based on the Swedish Cancer Environment Registry. Scand J Soc Med 14:151-160.
329. Vassilopoulou-Sellin R, Palmer L, Taylor S, et al. 1999. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696-705.
330. Verkooijen HM, Fioretta G, Pache J-C, et al. 2003. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14:13-17.
331. Vini L, Hyer SL, Marshall J, et al. 2003. Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer 97:2736-2742.
332. Wang J-X, Inskip PD, Boice JD Jr., et al. 1990a. Cancer incidence among medical diagnostic x-ray workers in China, 1950 to 1985. Int J Cancer 45:889-895.
333. Wang Z, Boice JD Jr., Luxin W, et al. 1990b. Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst 82:478-485.
334. Ward JM, Ohshima M. 1986. The role of iodine in carcinogenesis. Adv Exp Med Biol 206:529-542.
335. Wattenberg LW. 1983. Inhibition of neoplasia by minor dietary constituents. Cancer Res 43(suppl):2448S-2453S.
336. Weeke J, Hansen AP. 1975. Serum TSH and serum T3 levels during normal menstrual cycles and during cycles on oral contraceptives. Acta Endocrinol 79:431-438.
337. Wegelin C. 1928. Malignant disease of the thyroid gland and its relation to goitre in man and animal. Cancer Rev 3:297-313.
338. Williams D. 2002. Cancer after nuclear fallout: Lessons from the Chernobyl accident. Nat Rev Cancer 2:543-549.
339. Williams ED, Doniach I, Bjarnason O, et al. 1977. Thyroid cancer in an iodine-rich area. A histopathological study. Cancer 39:215-222.
340. Williams ED. 1995. Mechanisms and pathogenesis of thyroid cancer in animals and man. Mutat Res 333:123-129.
341. Williams ED. 1979. The aetiology of thyroid tumors. Clin Endocrinol Metab 8:193-207.
342. Williams ED. 1990. TSH and thyroid cancer. Horm Metab Res Suppl 23:72-75.
343. Williams RR. 1976. Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, TSH and MSH. Lancet 1:996-999.
344. Wingren G, Hatschek T, Axelson O. 1993. Determinants of papillary cancer of the thyroid. Am J Epidemiol 138:482-491.
345. Winship T, Rosvoll RV. 1970. Thyroid carcinoma in childhood: Final report on a 20 year study. Clin Proc Children's Hosp 26:327-348.
346. Wright PA, Lemoine NR, Mayall ES, et al. 1989. Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation. Br J Cancer 60:576-577.
347. Yamashita S, Shibata Y, Hoshi M, et al., eds. Chernobyl: Message for the 21st Century. Amsterdan, Elsevier, 2002.
348. Yane K, Kitahori Y, Konishi N, et al. 1994. Expression of the estrogen receptor in human thyroid neoplasms. Cancer Lett 84:59-66.
349. Yin F, Giuliano AE, Van Herle AJ. 1999. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 9:369-376.
350. Zheng TZ, Holford TR, Chen YT, et al. 1996. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer 67:504-509.
351. Zimmermann MB, Kohrle J. 2002. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: Biochemistry and relevance to public health. Thyroid 12:867-878.
352. Zivaljevic V, Vlajinac H, Jankovic R, et al. 2003. Case-control study of female thyroid cancer-menstrual, reproductive and hormonal factors. Eur J Cancer Prev 12:63-66.